• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肝卟啉症:现状与未来挑战。

The acute hepatic porphyrias: current status and future challenges.

机构信息

Department of Dermatology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

出版信息

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):593-605. doi: 10.1016/j.bpg.2010.08.010.

DOI:10.1016/j.bpg.2010.08.010
PMID:20955962
Abstract

The porphyrias are predominantly inherited metabolic disorders, which result from a specific deficiency of one of the eight enzymes along the pathway of haem biosynthesis. Historically, they have been classified into hepatic and erythropoietic forms, based on the primary site of expression of the prevailing dysfunctional enzyme. From a clinical point of view, however, it is more convenient to subdivide them into acute and non-acute porphyrias, thereby primarily considering the potential occurrence of life-threatening acute neurovisceral attacks. Unrecognised or untreated, such an acute porphyric attack is associated with a significant mortality of up to 10%. The acute hepatic porphyrias comprise acute intermittent porphyria, variegate porphyria, hereditary coproporphyria, and δ-aminolevulinic acid dehydratase deficiency porphyria. Making a precise diagnosis may be difficult because the different types of porphyrias may show overlapping clinical and biochemical characteristics. To date, the therapeutic possibilities are limited and mainly symptomatic. In this overview we report on what is currently known about pathogenesis, clinic, diagnostics, and therapy of the acute hepatic porphyrias. We further point out actual and future challenges in the management of these diseases.

摘要

卟啉病主要是遗传性代谢紊乱,是由于血红素生物合成途径中某一特定酶的缺乏引起的。历史上,根据主要表达的功能失调酶的类型,它们被分为肝性和红细胞生成性卟啉病。然而,从临床角度来看,将它们进一步细分为急性和非急性卟啉病更为方便,主要考虑到危及生命的急性神经内脏发作的潜在发生。如果不被识别或不治疗,这种急性卟啉病发作与高达 10%的显著死亡率相关。急性肝性卟啉病包括急性间歇性卟啉病、变异性卟啉病、遗传性粪卟啉病和 δ-氨基酮戊酸脱水酶缺乏性卟啉病。由于不同类型的卟啉病可能表现出重叠的临床和生化特征,因此做出准确的诊断可能具有挑战性。迄今为止,治疗的可能性有限,主要是对症治疗。在这篇综述中,我们报告了目前对急性肝性卟啉病的发病机制、临床、诊断和治疗的了解。我们进一步指出了这些疾病管理中的当前和未来的挑战。

相似文献

1
The acute hepatic porphyrias: current status and future challenges.急性肝卟啉症:现状与未来挑战。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):593-605. doi: 10.1016/j.bpg.2010.08.010.
2
Acute porphyrias in the Argentinean population: a review.阿根廷人群中的急性卟啉病:综述
Cell Mol Biol (Noisy-le-grand). 2003 Jun;49(4):493-500.
3
Erythropoietic and hepatic porphyrias.红细胞生成性和肝性卟啉病
J Inherit Metab Dis. 2000 Nov;23(7):641-61. doi: 10.1023/a:1005645624262.
4
A family with acute intermittent porphyria.一个患有急性间歇性卟啉症的家庭。
J Coll Physicians Surg Pak. 2008 May;18(5):316-8.
5
Hepatic porphyria: A narrative review.肝性卟啉病:一篇叙述性综述。
Indian J Gastroenterol. 2016 Nov;35(6):405-418. doi: 10.1007/s12664-016-0698-0. Epub 2016 Oct 31.
6
Human hereditary hepatic porphyrias.人类遗传性肝卟啉症。
Clin Chim Acta. 2002 Nov;325(1-2):17-37. doi: 10.1016/s0009-8981(02)00276-0.
7
Drugs and acute porphyrias: reasons for a hazardous relationship.药物与急性卟啉病:危险关系的成因
Postgrad Med. 2014 Nov;126(7):108-20. doi: 10.3810/pgm.2014.11.2839.
8
Modern diagnosis and management of the porphyrias.卟啉病的现代诊断与管理
Br J Haematol. 2006 Nov;135(3):281-92. doi: 10.1111/j.1365-2141.2006.06289.x. Epub 2006 Sep 4.
9
Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.意大利卟啉病的分子特征:诊断流程图
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.
10
Neurovisceral porphyrias: what a hematologist needs to know.神经内脏卟啉病:血液科医生需要了解的内容。
Hematology Am Soc Hematol Educ Program. 2005:24-30. doi: 10.1182/asheducation-2005.1.24.

引用本文的文献

1
Comparison of Pyrazinamide with Isoniazid for Their Effects on the Heme Biosynthetic Pathway in Mouse Liver.吡嗪酰胺与异烟肼对小鼠肝脏血红素生物合成途径影响的比较
Metabolites. 2025 May 28;15(6):355. doi: 10.3390/metabo15060355.
2
Characterizing hepatic porphyria: Insights from a quaternary care hospital in Bogotá, Colombia (2013-2023).哥伦比亚波哥大一家四级护理医院对肝性卟啉病的特征分析(2013 - 2023年)
J Int Med Res. 2025 Mar;53(3):3000605251325183. doi: 10.1177/03000605251325183. Epub 2025 Mar 21.
3
[An overview of porphyrias].[卟啉病概述]
Dermatologie (Heidelb). 2024 Jul;75(7):539-547. doi: 10.1007/s00105-024-05370-3. Epub 2024 Jun 20.
4
Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria.急性间歇性卟啉病的预防性血红素精氨酸输注
Front Pharmacol. 2021 Oct 6;12:712305. doi: 10.3389/fphar.2021.712305. eCollection 2021.
5
Acute Variegate Porphyria in a Professional Bodybuilder after Starting a High-protein Diet and Treatment with Testosterone.一名职业健美运动员在开始高蛋白饮食并接受睾酮治疗后患上急性间歇性卟啉病。
Acta Derm Venereol. 2021 Mar 11;101(3):adv00412. doi: 10.2340/00015555-3769.
6
A Unique Neuropsychiatric Syndrome in Variant Hereditary Coproporphyria: Case Report and Review of the Literature.变异型遗传性粪卟啉病中的一种独特神经精神综合征:病例报告及文献综述
J Hematol. 2017 Mar;6(1):21-24. doi: 10.14740/jh315w. Epub 2017 Mar 21.
7
Benefits of prophylactic heme therapy in severe acute intermittent porphyria.预防性血红素疗法在严重急性间歇性卟啉症中的益处。
Mol Genet Metab Rep. 2019 Jan 30;19:100450. doi: 10.1016/j.ymgmr.2019.01.002. eCollection 2019 Jun.
8
A mouse model of hereditary coproporphyria identified in an ENU mutagenesis screen.在ENU诱变筛选中鉴定出的遗传性粪卟啉原血症小鼠模型。
Dis Model Mech. 2017 Aug 1;10(8):1005-1013. doi: 10.1242/dmm.029116. Epub 2017 Jun 9.
9
A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.肽转运体2的一种变体可预测卟啉症相关肾病的严重程度。
J Am Soc Nephrol. 2017 Jun;28(6):1924-1932. doi: 10.1681/ASN.2016080918. Epub 2016 Dec 28.
10
Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.急性间歇性卟啉症患者循环细胞中的血红素生物合成与抗氧化酶
PLoS One. 2016 Oct 27;11(10):e0164857. doi: 10.1371/journal.pone.0164857. eCollection 2016.